Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication December 22, 2015
- Accepted for publication March 14, 2016
- Published online September 1, 2016.
Article Versions
- previous version (April 21, 2016 - 13:02).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Author Information
- Mika Naganawa*,1,
- Rikki N. Waterhouse*,2,
- Nabeel Nabulsi1,
- Shu-Fei Lin1,
- David Labaree1,
- Jim Ropchan1,
- Sanela Tarabar2,
- Nicholas DeMartinis2,
- Adam Ogden2,
- Anindita Banerjee2,
- Yiyun Huang1 and
- Richard E. Carson1
- 1Department of Radiology and Biomedical Imaging, PET Center, Yale School of Medicine, New Haven, Connecticut; and
- 2Pfizer Worldwide Research and Development, Cambridge, Massachusetts
- For correspondence contact: Mika Naganawa, Department of Radiology and Biomedical Imaging, PET Center, Yale School of Medicine, P.O. Box 208048, New Haven, CT 06520. E-mail: mika.naganawa{at}yale.edu
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Synthesis and preclinical evaluation of [11C]MTP38 as a novel PET ligand for phosphodiesterase 7 in the brain
- Target Engagement of a Phosphodiesterase 2A Inhibitor Affecting Long-Term Memory in the Rat
- Imaging the Enzyme 11{beta}-Hydroxysteroid Dehydrogenase Type 1 with PET: Evaluation of the Novel Radiotracer 11C-AS2471907 in Human Brain
- Evaluation of the Lysophosphatidic Acid Receptor Type 1 Radioligand 11C-BMT-136088 for Lung Imaging in Rhesus Monkeys
- Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme